Tag: Stelo
Dexcom to introduce OTC glucose sensor
March 6, 2024HME News Staff
SAN DIEGO – Dexcom has received clearance from the U.S. Food and Drug Administration for its Stelo by Dexcom, a continuous glucose monitor that will be available for people with Type 2 diabetes without a prescription. “Dexcom continues to lead innovation in the CGM market, with a long list of first-in-market advances,” said Jake Leach, executive vice president and COO. “Dexcom was the first to connect CGM to multiple insulin delivery devices, the first to connect CGM to a...
Continuous Glucose Monitor (CGM), Dexcom, Diabetes, Stelo
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams